Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
- PMID: 19088106
- DOI: 10.1093/humrep/den417
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
Abstract
Background: The development of new blood vessels plays an essential role in growth and survival of endometriosis. Epigallocatechin gallate (EGCG) from green tea has powerful anti-angiogenic properties and our aim was to evaluate these properties in experimental endometriosis.
Methods and results: Eutopic endometrium from endometriosis patients was transplanted s.c. to severely compromised immunodeficient mice, randomly treated i.p. with EGCG (anti-angiogenic and -oxidant), Vitamin E (a non-angiogenic antioxidant) or saline for 2 weeks. The endometrial implant, including adjacent host outer skin and subcutaneous layers plus inner abdominal muscle and peritoneum, was collected. New microvessels were determined by species-specific immunohistochemistry. Angiogenic factors in lesions and abdominal muscle were detected by quantitative real-time PCR. Apoptosis was studied by terminal deoxynucleotidyltransferase-mediated dUTP nick-end labelling and quantitative real-time PCR. In saline control, endometrial implants developed new blood vessels with proliferating glandular epithelium and were tightly adhered to host subcutaneous and abdominal muscle layers. After EGCG, endometriotic lesions were smaller than control (P < 0.05), and glandular epithelium was smaller and eccentrically distributed. Angiogenesis in lesions from the implant and adjacent tissues was under-developed, and microvessel size and density were lower (both P < 0.01) than control. mRNA for angiogenic vascular endothelial growth factor A, but not hypoxia inducible factor 1, alpha subunit, was significantly down-regulated in lesions after EGCG (P < 0.05). In addition, apoptosis in the lesions was more obvious, and nuclear factor kappa B and mitogen activated protein kinase 1 mRNA levels were up-regulated (P < 0.05) after EGCG treatment. No differences were observed with Vitamin E treatment.
Conclusions: EGCG significantly inhibits the development of experimental endometriosis through anti-angiogenic effects.
Similar articles
-
Animal models for anti-angiogenic therapy in endometriosis.J Reprod Immunol. 2013 Mar;97(1):85-94. doi: 10.1016/j.jri.2012.10.012. J Reprod Immunol. 2013. PMID: 23432875 Review.
-
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.Angiogenesis. 2013 Jan;16(1):59-69. doi: 10.1007/s10456-012-9299-4. Epub 2012 Sep 5. Angiogenesis. 2013. PMID: 22948799
-
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.Fertil Steril. 2011 Oct;96(4):1021-8. doi: 10.1016/j.fertnstert.2011.07.008. Epub 2011 Aug 6. Fertil Steril. 2011. PMID: 21821246
-
The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.Gynecol Obstet Invest. 2008;66 Suppl 1:10-8. doi: 10.1159/000148026. Epub 2008 Oct 21. Gynecol Obstet Invest. 2008. PMID: 18936547 Review.
-
Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.Hum Reprod. 2008 Oct;23(10):2308-18. doi: 10.1093/humrep/den245. Epub 2008 Jul 4. Hum Reprod. 2008. PMID: 18603648
Cited by
-
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.Nutrients. 2024 Feb 17;16(4):559. doi: 10.3390/nu16040559. Nutrients. 2024. PMID: 38398883 Free PMC article. Review.
-
Distinct molecular targets of ProEGCG from EGCG and superior inhibition of angiogenesis signaling pathways for treatment of endometriosis.J Pharm Anal. 2024 Jan;14(1):100-114. doi: 10.1016/j.jpha.2023.09.005. Epub 2023 Sep 11. J Pharm Anal. 2024. PMID: 38352946 Free PMC article.
-
Diet in Prevention and Treatment of Endometriosis: Current State of Knowledge.Curr Nutr Rep. 2024 Mar;13(1):49-58. doi: 10.1007/s13668-024-00518-y. Epub 2024 Feb 7. Curr Nutr Rep. 2024. PMID: 38324218 Review.
-
In Vitro and In Silico Protocols for the Assessment of Anti-Tick Compounds from Pinus roxburghii against Rhipicephalus (Boophilus) microplus Ticks.Animals (Basel). 2023 Apr 18;13(8):1388. doi: 10.3390/ani13081388. Animals (Basel). 2023. PMID: 37106951 Free PMC article.
-
Green Tea and Benign Gynecologic Disorders: A New Trick for An Old Beverage?Nutrients. 2023 Mar 16;15(6):1439. doi: 10.3390/nu15061439. Nutrients. 2023. PMID: 36986169 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical